Neuromuscular Blocking Agents in the ICU: Why Work Blindfolded?
- PMID: 33857989
- DOI: 10.1213/ANE.0000000000005353
Neuromuscular Blocking Agents in the ICU: Why Work Blindfolded?
Comment in
-
In Response.Anesth Analg. 2021 May 1;132(5):e74. doi: 10.1213/ANE.0000000000005354. Anesth Analg. 2021. PMID: 33857990 No abstract available.
Comment on
-
Neuromuscular Blockade Monitoring in Acute Respiratory Distress Syndrome: Randomized Controlled Trial of Clinical Assessment Alone or With Peripheral Nerve Stimulation.Anesth Analg. 2021 Apr 1;132(4):1051-1059. doi: 10.1213/ANE.0000000000005174. Anesth Analg. 2021. PMID: 33002927 Clinical Trial.
References
-
- Rezaiguia-Delclaux S, Laverdure F, Genty T, et al. Neuromuscular blockade monitoring in acute respiratory distress syndrome: randomized controlled trial of clinical assessment alone or with peripheral nerve stimulation. Anesth Analg. 2021;132:1051–1059.
-
- Murray MJ, DeBlock H, Erstad B, et al. Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. Crit Care Med. 2016;44:2079–2103.
-
- Papazian L, Aubron C, Laurent Brochard L, et al. SDRA: Les recommandations de la SRLF. 2019. SRLF; Available at: https://www.srlf.org/rfe-srlf-prise-en-charge-du-syndrome-dedetresse-res... . Accessed October 4, 2020.
-
- deBacker J, Hart N, Fan E. Neuromuscular blockade in the 21st century management of the critically ill patient.Chest. 2017151697706
-
- Greenberg SB, Vender J. The use of neuromuscular blocking agents in the ICU: where are we now?Crit Care Med. 20134113321344
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources